Prostate Cancer News and Research

Latest Prostate Cancer News and Research

PET/MRI reduces radiation exposure, improves lesion detectability in select cancers

A single-center observational study of more than 1,000 oncological examinations has demonstrated that positron emission tomography/magnetic resonance imaging (PET/MRI) facilitates cancer staging as well as PET/computed tomography (PET/CT) and improves lesion detectability in select cancers, potentially helping to promote fast, efficient local and whole-body staging in one step.

17 Sep 2020

UTHSC professor receives $455,000 grant to study cause of aggressive prostate cancer

Ramesh Narayanan, PhD, professor in the Department of Medicine and the Division of Hematology and Oncology at the University of Tennessee Health Science Center, has received a $455,000 grant from the National Cancer Institute for a two-year study of the underlying cause of the development of aggressive prostate cancer in African American men.

17 Sep 2020

New nanomedicine is efficient and less aggressive than conventional prostate cancer therapy

Prostate cancer is the most common type of cancer among European men; its incidence surpasses 100 cases per 100,000 people.

15 Sep 2020

Researchers receive $2.5 million grant to develop and analyze breast tumor organoids

Breast cancer is the second most common cancer diagnosed in women in the United States after skin cancer, and women with comorbidities (the presence of more than one condition/disease) often fare worse in terms of their breast cancer.

14 Sep 2020

High-intensity focused ultrasound technology shows promising outcomes for prostate cancer

High-intensity focused ultrasound (HIFU) - a technology used to treat localized prostate cancer - has shown adequate control of prostate cancer while avoiding major side effects of surgery or radiation therapy, according to a new study in The Journal of Urology®, Official Journal of the American Urological Association (AUA).

9 Sep 2020

Six genomics research projects receive grants to address the role of ethnicity in major cancers

Leading cancer scientists working with the New York Genome Center (NYGC) announced today that grants are being awarded to fund six projects that address the role of ethnicity in several major cancer types, taking advantage of the diversity of patients being treated at health care institutions throughout the New York City area.

8 Sep 2020

Focal high-intensity focused ultrasound ablation is an effective treatment for prostate cancer

For some prostate cancer patients, radical treatment (surgery or radiation) are treatment standards. However, these procedures may cause side effects including urinary incontinence or impotency.

8 Sep 2020

Understanding mechanisms in prostate cancer metastases can provide treatment opportunities

An increased awareness on a molecular level of what mechanisms prostate cancer cells use to become mobile and start spreading may in the long run provide new opportunities for treatment of aggressive prostate cancer.

3 Sep 2020

Dartmouth receives $2.5 million to develop device for detecting tumor left behind during surgery

Dartmouth engineers have been awarded a $2.5 million grant from the National Cancer Institute, part of the National Institutes of Health, to develop and test a device--a microendoscopic electrical impedance sensing probe-- that could be used by surgeons to detect prostate cancer still left in the body during surgery.

25 Aug 2020

Enzalutamide has added benefit for men with castration-resistant prostate cancer at high risk of metastasis

In 2018 and 2019, the German Institute for Quality and Efficiency in Health Care already investigated whether the drug enzalutamide has an advantage in comparison with the appropriate comparator therapy, i.e. in comparison with watchful waiting while maintaining ongoing conventional androgen deprivation therapy (ADT), for adult men with high-risk non-metastatic castration-resistant prostate cancer.

19 Aug 2020

Study shows how PIM kinases enhance cancer cell motility

PIM kinases are enzymes that promote metastatic growth and spread of cancer cells. Researchers from the University of Turku, Finland, have obtained new information on how the PIM kinases enhance cancer cell motility by regulating the formation of actin fibers in the cytoskeleton.

19 Aug 2020

PARP inhibitor can successfully treat a subset of advanced prostate cancer patients

Results from an international clinical trial found that men with advanced prostate cancer who have mutated BRCA1/BRCA2 genes can be treated successfully with a targeted therapy known as rucaparib, resulting in recent FDA approval.

15 Aug 2020

Radiation therapy delay for prostate cancer patients offers room for flexibility during the pandemic

For cancer patients receiving radiation treatment during a surge in COVID-19 cases, adhering to the stay-at-home orders of quarantine is not always an option.

13 Aug 2020

Study uses a statistical approach to reveal patterns of cancer incidence

QUT researchers have used nationwide cancer mapping statistics to develop a new mathematical model so health professionals can further question patterns relating to the disease.

13 Aug 2020

Developing a blood test for prostate cancer

Professor Pockley among researchers from the John van Geest Cancer Research Centre have recently developed a blood test for the detection of prostate cancer.

13 Aug 2020

Simple process could enhance personalization of cancer therapy

Researchers have developed a simplified process that could enhance personalization of cancer therapy based on a single nuclear medicine scan.

12 Aug 2020

Darolutamide shows indication of considerable added benefit in prostate cancer

Up to now, adult men with non-metastatic castration-resistant prostate cancer (nmCRPC) at high risk of developing metastatic disease usually continued their conventional androgen deprivation therapy (ADT) while the cancer was observed for the occurrence of metastases (so-called watchful waiting).

3 Aug 2020

New method to detect rare circulating tumor cells in blood samples

Metastasis - the development of tumor growth at a secondary site - is responsible for the majority of cancer-related deaths. It occurs when the primary tumor site sheds cancerous cells which are then circulated through the body via blood vessels or lymph nodes.

3 Aug 2020

New blood test can detect prostate cancer and confirm the stage of the disease

A new blood test developed by scientists and clinicians is able to detect the presence of prostate cancer and confirm how advanced it is.

30 Jul 2020

Combination of certain drugs can do more harm than good, shows study

A team of researchers at the Norwegian University of Science and Technology (NTNU) investigating how a certain type of drugs can kill cells has discovered that these drugs can do more harm than good when used in combination with other cancer treatments.

29 Jul 2020

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

PET/MRI reduces radiation exposure, improves lesion detectability in select cancers

UTHSC professor receives $455,000 grant to study cause of aggressive prostate cancer

New nanomedicine is efficient and less aggressive than conventional prostate cancer therapy

Researchers receive $2.5 million grant to develop and analyze breast tumor organoids

High-intensity focused ultrasound technology shows promising outcomes for prostate cancer

Six genomics research projects receive grants to address the role of ethnicity in major cancers

Focal high-intensity focused ultrasound ablation is an effective treatment for prostate cancer

Understanding mechanisms in prostate cancer metastases can provide treatment opportunities

Dartmouth receives $2.5 million to develop device for detecting tumor left behind during surgery

Enzalutamide has added benefit for men with castration-resistant prostate cancer at high risk of metastasis

Study shows how PIM kinases enhance cancer cell motility

PARP inhibitor can successfully treat a subset of advanced prostate cancer patients

Radiation therapy delay for prostate cancer patients offers room for flexibility during the pandemic

Study uses a statistical approach to reveal patterns of cancer incidence

Developing a blood test for prostate cancer

Simple process could enhance personalization of cancer therapy

Darolutamide shows indication of considerable added benefit in prostate cancer

New method to detect rare circulating tumor cells in blood samples

New blood test can detect prostate cancer and confirm the stage of the disease

Combination of certain drugs can do more harm than good, shows study

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in